TriClip Upholds 1-Year Procedural Safety in TR: TRILUMINATE Pivotal Early Results

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

TriClip Upholds 1-Year Procedural Safety in TR: TRILUMINATE Pivotal Early Results

Posted: 03/10/2025
Author:
Natalie Morrison, CRTonline.org
2025 News Articles March 10, 2025 Valve & Structural 2025 Tricuspid Valve interventions CRT CRT Annual Meetings

The TriClip device demonstrates procedural safety in severe, symptomatic tricuspid regurgitation patients (TR) at 1 year, and is safe in patients with cardiac implantable electronic device (CIED) leads, results from the TRILUMINATE Pivotal study show.
1-3 of 2828 results
1 2 3 4 5 Next »

Positive PATCH Trial Results Send PerQSeal Vascular Patch Heading for FDA Submission

Mar 11, 2025 by
Natalie Morrison, CRTonline.org

The PerQSeal resorbable vascular patch showed low rates of major vascular complications and rapid hemostasis rates when used for the closure of large bore arteriotomies in the US pivotal PATCH trial.

PEERLESS Registry Shows Safety, Efficacy in Large-Bore Thrombectomy for PE

Mar 11, 2025 by
Will Chu, CRTonline.org

Data from the PEERLESS registry cohort suggests that large-bore mechanical thrombectomy (LBMT) is safe and effective for intermediate-risk pulmonary embolism (PE) patients unable to receive thrombolytics.

Results of Auryon BTK Study Show Positive Outcomes for Use of Auryon 355-nm Laser to Treat Patients With CLTI

Mar 11, 2025 by
Bailey G. Salimes, CRTonline.org

In addition to a high rate of freedom from target lesion revascularization (TLR), patients with chronic limb-threatening ischemia (CLTI) experience several improvements in quality-of-life measures when treated with the Auryon Laser Atherectomy System for infrapopliteal arterial disease.

1-3 of 2828 results
1 2 3 4 5 Next »

Most Viewed Pages

Laser Atherectomy Enhances Stent Expansion in Resistant Patients: LASER-EXPAND Trial

CRABBIS Trial Compares Stenting Techniques in PCI

Crushing Ticagrelor Makes No Difference in Platelet Activity for PCI Patients Receiving Fentanyl

Balloon-Expandable Valves Outperform Self-Expanding Valves in TAVR Outcomes, Study Concludes

Patient Prosthesis Mismatch Not Associated With Lowered Quality of Life at 1-Year Post-TAVI

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

TriClip Upholds 1-Year Procedural Safety in TR: TRILUMINATE Pivotal Early Results

Positive PATCH Trial Results Send PerQSeal Vascular Patch Heading for FDA Submission

PEERLESS Registry Shows Safety, Efficacy in Large-Bore Thrombectomy for PE

Results of Auryon BTK Study Show Positive Outcomes for Use of Auryon 355-nm Laser to Treat Patients With CLTI

Most Viewed Pages

Explore the Site

Stay Connected